SCHEMBL30708693

SCHEMBL30708693

NC(=O)c1cnc2ccnn2c1.[N]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.53
NNMT P40261 3/20 0.41
F7 P08709 1/20 0.41
F3 P13726 1/20 0.41
SARM1 Q6SZW1 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
SIRT6 Q8N6T7 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
SIRT3 Q9NTG7 1/20 0.41
SIRT5 Q9NXA8 1/20 0.41
SIRT4 Q9Y6E7 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KIT P10721 6/20 0.38
DDR1 Q08345 5/20 0.38
PDE4B Q07343 2/20 0.38
PDE4D Q08499 2/20 0.38
MAP4K4 O95819 1/20 0.37
NTRK1 P04629 1/20 0.37
DDR2 Q16832 1/20 0.37
FYN P06241 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25419641 0.98 LMNA (0.54) LMNANNMTF7F3SARM1
SCHEMBL557159 0.83 ALKBH2 (0.47) LMNAKITDDR1PDE4BPDE4D
SCHEMBL3608804 0.81 KIT (0.39) LMNAKITDDR1PDE4BPDE4D
SCHEMBL18825814 0.78 NTRK1 (0.47) KITDDR1NTRK1DDR2
SCHEMBL21855118 0.75 KIT (0.50) KITDDR1DDR2
SCHEMBL3611630 0.74 MAP4K4 (0.46) LMNASMN1; SMN2KITDDR1MAP4K4
SCHEMBL2448509 0.74 ABL1 (0.41) KITDDR1PDE4BPDE4DNTRK1
SCHEMBL6886297 0.72 DYRK1A (0.45) LMNANNMTSMN1; SMN2PDE4BMAP4K4
SCHEMBL7067259 0.72 TP53 (0.43) SMN1; SMN2KITDDR1NTRK1
SCHEMBL20556098 0.72 LMNA (0.62) LMNASMN1; SMN2FYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117120442-A Tricyclic compounds useful for treating cancer, autoimmune disorders, and inflammatory disorders 薛定谔公司 2023-11-24 CN disclosed